Oruka Therapeutics, Inc. (ORKA) Earnings
Oruka Therapeutics, Inc. is expected to report next earnings on November 11, 2026 (in NaN days), with a consensus EPS estimate of $-0.58. ORKA has beaten EPS estimates in 3 of its last 6 reported quarters (average surprise +7.9% over the last four).
Next earnings
Nov 11, 2026in NaN days
EPS est $-0.58 · Revenue est —
Track record
Beat EPS in 3 of 6 quarters
Avg surprise +7.9% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 10, 2026 | $-0.51 | $-0.55 | -7.3% | — | — |
| May 13, 2026 | $-0.52 | $-0.48 | +7.7% | — | — |
| Mar 12, 2026 | $-0.64 | $-0.45 | +29.3% | — | — |
| Nov 12, 2025 | $-0.56 | $-0.55 | +1.8% | — | — |
| Feb 27, 2025 | $-0.68 | $-0.96 | -41.2% | — | — |
| Nov 13, 2024 | $-0.40 | $-1.46 | -265.0% | — | — |
| Apr 25, 2024 | — | $-0.14 | — | — | — |
| Sep 29, 2022 | — | $-1.94 | — | — | — |
| Jun 29, 2019 | — | $-13.64 | — | — | — |
| Sep 29, 2018 | — | $-24.71 | — | — | — |
| Dec 30, 2017 | — | $-76.99 | — | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.